| 阿霉素诱导心脏毒性的发病机制与防治 |
| |
| 引用本文： | 王青伟,丁荣晶.阿霉素诱导心脏毒性的发病机制与防治[J].自然杂志,2021,44(2):103-108. |
| |
| 作者姓名： | 王青伟 丁荣晶 |
| |
| 作者单位： | 北京大学人民医院，北京 100044 |
| |
| 摘 要： | 阿霉素可治疗多种恶性肿瘤，但心脏毒性限制了其在临床的广泛应用。阿霉素诱导的心脏毒性的发病机制尚不明确，防治方面现有证据仍不足。文章梳理了有关阿霉素诱导心脏毒性致病机制与防治的最新研究进展，为进一步探索阿霉素诱导的心脏毒性提供更广泛的治疗思路和实验室依据。
|
| 关 键 词： | 阿霉素 心脏毒性 发病机制 |
| 收稿时间： | 2021-12-12 |
Pathogenic mechanism,prevention and treatment of doxorubicin-inducedcardiotoxicity |
| |
| WANG Qingwei,DING Rongjing.Pathogenic mechanism,prevention and treatment of doxorubicin-inducedcardiotoxicity[J].Chinese Journal of Nature,2021,44(2):103-108. |
| |
| Authors: | WANG Qingwei DING Rongjing |
| |
| Institution: | Peking University People's Hospital, Beijing 100044, China |
| |
| Abstract: | Doxorubicin can be used to treat a variety of malignant tumors, but its wide clinical application is limited by doxorubicin-induced cardiotoxicity. The pathogenic mechanism of doxorubicin-induced cardiotoxicity remains unclear, and the available evidence
for prevention and treatment is still insufficient. This article reviews the pathogenic mechanisms, prevention and treatment of
doxorubicin-induced cardiotoxicity, aiming to provide a more extensive treatment idea and laboratory evidence for further exploration
of doxorubicin-induced cardiotoxicity. |
| |
| Keywords: | |
|
| 点击此处可从《自然杂志》浏览原始摘要信息 |
| 点击此处可从《自然杂志》下载免费的PDF全文 |
|
